Cary Street Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Cary Street Partners’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$329K	Hold	3,327	–	–	0.01%	779
2026 Q1	$288K	Hold	3,327	–	–	0.01%	726
2025 Q4	$282K	Hold	3,327	–	–	0.01%	744
2025 Q3	$241K	Hold	3,327	–	–	0.01%	740
2025 Q2	$218K	Hold	3,327	–	–	0.01%	743
2025 Q1	$235K	Hold	3,327	–	–	0.01%	704
2024 Q4	$219K	Buy	+3,327	New	+$229K	0.01%	694

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Cary Street Partners's IHE Position: Q2 2026 in Review

Cary Street Partners held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 3,327 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #779.

Cary Street Partners first reported a position in IHE in Q4 2024 and has held it in 7 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Cary Street Partners held 3,327 shares of iShares US Pharmaceuticals ETF worth $329K as of Q2 2026.
Cary Street Partners left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #779 holding.
Cary Street Partners first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.